This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

UnitedHealth Group Drs. Deneen Vojta And Richard Smith To Address The 25th Anniversary Nobel Peace Prize Forum

Deneen Vojta, M.D., and Richard Smith, M.D., two of UnitedHealth Group’s leading chronic disease experts, will address the 25 th Anniversary Nobel Peace Prize Forum, March 8-10 at Augsburg College in Minneapolis.

Dr. Vojta, senior vice president of the UnitedHealth Center for Health Reform & Modernization and chief clinical officer of the Diabetes Prevention and Control Alliance, and Dr. Richard Smith, director of the UnitedHealth Chronic Disease Initiative, will participate in the forum’s first-ever “Science and Health Day” Saturday, March 9. Their presentation, “Diabesity: Disease Gone Global,” will consider the “diabesity” dilemma – the clinical and behavioral chain that leads from childhood obesity to prediabetes to type 2 diabetes – from a global perspective.

Diabetes is one of the greatest health and economic challenges of the 21 st century, with more than 350 million people worldwide living with the disease, a figure that is expected to rise to more than 550 million within 20 years, according to the International Diabetes Federation (IDF). Vojta and Smith will describe concepts for successful global strategies to address this most pressing public health and economic crisis, including community-based programs that have been clinically proven to help prevent or delay the onset of type 2 diabetes.

“It is a great honor to speak at this year’s 25 th Anniversary Nobel Peace Prize Forum,” said Vojta. “The timing of this conference is critical, since the world’s diabesity epidemic is evolving from a significant public health issue to one that, if gone unchecked, poses a true threat to global prosperity.”

Smith said: “We are grateful for the opportunity to address the Nobel Peace Prize Forum and help draw attention to a true global pandemic. The prevalence of prediabetes and diabetes has increased dramatically over the past two decades on a parallel track with the global increase in obesity and unsustainable lifestyles.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,856.78 -278.94 -1.54%
S&P 500 2,071.26 -29.78 -1.42%
NASDAQ 4,927.37 -55.4390 -1.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs